Lung Neoplasms Clinical Trials

32 recruiting

Lung Neoplasms Trials at a Glance

35 actively recruiting trials for lung neoplasms are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 13 trials, with the heaviest enrollment activity in Guangzhou, Aurora, and Berlin. Lead sponsors running lung neoplasms studies include AstraZeneca, Medical University of Vienna, and Rutgers, The State University of New Jersey.

Browse lung neoplasms trials by phase

Treatments under study

About Lung Neoplasms Clinical Trials

Looking for clinical trials for Lung Neoplasms? There are currently 32 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lung Neoplasms trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lung Neoplasms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 35 trials

Recruiting
Not Applicable

Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study

Leptomeningeal MetastasisLung Neoplasms, Non-Small Cell Lung Cancer
Second Affiliated Hospital of Nanchang University30 enrolled1 locationNCT07398599
Recruiting
Phase 2

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Lung NeoplasmsSmall Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+3 more
Pfizer40 enrolled3 locationsNCT07476287
Recruiting
Not Applicable

MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients

Lung Neoplasms
West China Hospital2,000 enrolled1 locationNCT07509333
Recruiting

To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)

Neoadjuvant TherapyLung NeoplasmsMinimal Residual Disease+1 more
Peking University People's Hospital100 enrolled1 locationNCT07291921
Recruiting

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

Lung Neoplasms
AstraZeneca60,000 enrolled2 locationsNCT07143110
Recruiting

DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns

Lung Neoplasms
AstraZeneca200 enrolled7 locationsNCT07109154
Recruiting
Phase 1

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Ovarian NeoplasmsStomach NeoplasmsLung Neoplasms+5 more
National Cancer Institute (NCI)100 enrolled1 locationNCT06885697
Recruiting

Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer

Lung Neoplasms
University of Colorado, Denver500 enrolled1 locationNCT01580982
Recruiting

Specimen Banking From Patients With Lung Cancer

Lung Neoplasms
University of Colorado, Denver2,000 enrolled1 locationNCT01585675
Recruiting
Not Applicable

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

Lung CancerLung Neoplasms
Wake Forest University Health Sciences1,160 enrolled1 locationNCT04577599
Recruiting

68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors

Breast Neoplasms、Lung Neoplasms、Pancreatic Neoplasms
Peking University First Hospital10 enrolled1 locationNCT07331532
Recruiting
Not Applicable

Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals

Lung CancerLung NeoplasmsCancer Screening+2 more
National University Hospital, Singapore140 enrolled1 locationNCT07358715
Recruiting

Circulating Tumor Cells (CTC) in Lung Cancer

Lung Neoplasms
Shadia Jalal80 enrolled2 locationsNCT02630615
Recruiting
Not Applicable

TELESCOPE- TELEhealth Shared Decision-making COaching

Lung Neoplasms
Rutgers, The State University of New Jersey594 enrolled2 locationsNCT05491213
Recruiting
Phase 2

Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer

Lung NeoplasmsThoracic NeoplasmsLung Diseases+1 more
Shanghai Pulmonary Hospital, Shanghai, China15 enrolled1 locationNCT06758700
Recruiting
Not Applicable

Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer

Exercise TherapyPatient Reported Outcome MeasuresPostoperative Complications+2 more
Zhongshan People's Hospital, Guangdong, China736 enrolled1 locationNCT05990946
Recruiting
Not Applicable

TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics

Lung Neoplasms
Rutgers, The State University of New Jersey91 enrolled1 locationNCT07165691
Recruiting

Real World Registry for Use of the Ion Endoluminal System

Lung CancerLung NeoplasmsNeoplasms+6 more
Intuitive Surgical3,000 enrolled16 locationsNCT06004440
Recruiting
Phase 2

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

Breast NeoplasmsLung Neoplasms
Brown University60 enrolled1 locationNCT06974604
Recruiting

ALG-LungCancerRegistry (SAFRO2202)

Lung Neoplasms
Société Algérienne de Formation et de Recherche en Oncologie3,750 enrolled21 locationsNCT07161882